Inventor · disambiguated record
David Lapointe
Also filed as: LAPOINTE DAVID
6 granted patents·2 pending applications·13 citations·filing 2018–2023
77Inventor score
Top patents by PatentIndex Score
8 records- 0192US10392376B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Aug 27, 2019·7 cites·32 claims
- 0286US11753369B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Granted Sep 12, 2023·1 cites·20 claims
- 0386US10800769B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Oct 13, 2020·2 cites·16 claims
- 0482US11332438B2Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted May 17, 2022·2 cites·23 claims
- 0577US2024092731A1Creatine prodrugs, compositions and methods of use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0674US10894052B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Jan 19, 2021·1 cites·32 claims
- 0767US11434233B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2020·Granted Sep 6, 2022·0 cites·21 claims
- 0853US2024342185A1SMALL MOLECULES INHIBITORS OF CYCLIC GMP-AMP SYNTHASE (cGAS)SCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lapointe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →